EMG
AGIO icon

ETF Managers Group’s Agios Pharmaceuticals AGIO Stock Holding History

ETF Managers Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$570K Buy
24,797
+370
+2% +$9.83K 0.02% 413
2022
Q4 		$686K Buy
24,427
+890
+4% +$25.1K 0.03% 246
2022
Q3 		$666K Buy
23,537
+911
+4% +$24.4K 0.02% 287
2022
Q2 		$506K Buy
22,626
+9,168
+68% +$207K 0.01% 473
2022
Q1 		$395K Buy
13,458
+225
+2% +$6.88K 0.01% 507
2021
Q4 		$444K Buy
13,233
+630
+5% +$25.4K 0.01% 533
2021
Q3 		$582K Buy
12,603
+969
+8% +$46.8K 0.01% 496
2021
Q2 		$623K Buy
11,634
+2,579
+28% +$144K 0.01% 417
2021
Q1 		$446K Buy
9,055
+1,218
+16% +$60.3K 0.01% 495
2020
Q4 		$349K Buy
7,837
+696
+10% +$27.5K 0.01% 519
2020
Q3 		$246K Buy
7,141
+355
+5% +$15.6K 0.01% 552
2020
Q2 		$360K Buy
6,786
+2,710
+66% +$125K 0.01% 329
2020
Q1 		$144K Buy
4,076
+416
+11% +$19.2K 0.01% 499
2019
Q4 		$176K Buy
3,660
+839
+30% +$31.7K 0.01% 522
2019
Q3 		$97K Sell
2,821
-30
-1% -$1.24K ﹤0.01% 521
2019
Q2 		$142K Buy
2,851
+1,102
+63% +$58.9K ﹤0.01% 519
2019
Q1 		$118K Buy
1,749
+157
+10% +$9.14K 0.01% 475
2018
Q4 		$73K Buy
1,592
+216
+16% +$13.3K ﹤0.01% 530
2018
Q3 		$106K Buy
1,376
+144
+12% +$11.6K ﹤0.01% 474
2018
Q2 		$642K Buy
1,232
+29
+2% +$2.53K 0.05% 160
2018
Q1 		$89K Buy
1,203
+150
+14% +$11.6K 0.01% 310
2017
Q4 		$63K Buy
1,053
+150
+17% +$9.44K ﹤0.01% 450
2017
Q3 		$60K Buy
903
+82
+10% +$4.92K 0.01% 253
2017
Q2 		$42K Buy
+821
New +$42K ﹤0.01% 511
2016
Q1 		$33K Buy
+567
New +$24.2K 0.02% 261

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

ETF Managers Group's AGIO Position: Q1 2023 in Review

ETF Managers Group increased its Agios Pharmaceuticals (AGIO) stake by 1.5% in Q1 2023, buying an estimated $9.83K and bringing the position to 24,797 shares worth $570K. The position accounts for 0.02% of the portfolio, ranked #413.

ETF Managers Group first reported a position in AGIO in Q1 2016 and has held it in 25 quarters since. The position peaked at $686K in Q4 2022. 164 funds tracked by Wall St. Rank hold AGIO as of Q1 2023.

  • ETF Managers Group held 24,797 shares of Agios Pharmaceuticals worth $570K as of Q1 2023.
  • ETF Managers Group bought 370 Agios Pharmaceuticals shares in Q1 2023, an estimated $9.83K.
  • Agios Pharmaceuticals made up 0.02% of ETF Managers Group's portfolio in Q1 2023, its #413 holding.
  • ETF Managers Group first reported a position in Agios Pharmaceuticals in Q1 2016 and has held it in 25 quarters since.
  • ETF Managers Group's Agios Pharmaceuticals position peaked at $686K in Q4 2022.
  • 164 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.